COVID – 19 | Vaccination Update – Day 481

ad
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children

India’s COVID-19 vaccination coverage has crossed 190.65 Crore (1,90,81,89,322today. More than 12 lakh (12,89,175) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10405979
2nd Dose 10026977
Precaution Dose 4977783
FLWs 1st Dose 18417266
2nd Dose 17560361
Precaution Dose 8054779
Age Group 12-14 years 1st Dose 31065899
2nd Dose 11011173
Age Group 15-18 years 1st Dose 58841944
2nd Dose 43560045
Age Group 18-44 years 1st Dose 556416780
2nd Dose 483326725
Precaution Dose 330067
Age Group 45-59 years 1st Dose 203097310
2nd Dose 189291429
Precaution Dose 888944
Over 60 years 1st Dose 126988863
2nd Dose 117972541
Precaution Dose 15954457
Cumulative 1st dose administered 1005234041
Cumulative 2nd dose administered 872749251
Precaution Dose 30206030
Total 1908189322

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 11th April, 2022 (481st Day)
HCWs 1st Dose 52
2nd Dose 673
Precaution Dose 12404
FLWs 1st Dose 74
2nd Dose 1216
Precaution Dose 23466
Age Group 12-14 years 1st Dose 144649
2nd Dose 335997
Age Group 15-18 years 1st Dose 28103
2nd Dose 108585
Age Group 18-44 years 1st Dose 44515
2nd Dose 333919
Precaution Dose 11812
Age Group 45-59 years 1st Dose 11003
2nd Dose 77613
Precaution Dose 25814
Over 60 years 1st Dose 5857
2nd Dose 52635
Precaution Dose 70788
Cumulative 1st dose administered 234253
Cumulative 2nd dose administered 910638
Precaution Dose 144284
Total 1289175

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply